ADC Therapeutics (ADCT) Other Operating Expenses (2020 - 2026)
ADC Therapeutics (ADCT) posted quarterly Other Operating Expenses of $16.3 million for Q1 2026, up 29.4% year-on-year from $12.6 million in Q1 2025, and up 37.28% on a QoQ basis from $11.9 million in Q3 2025.
ADC Therapeutics (ADCT) Other Operating Expenses (2020 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Other Operating Expenses for 7 consecutive years, with $16.3 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.32 Mn |
| Sep 30, 2025 | 11.89 Mn |
| Jun 30, 2025 | 10.98 Mn |
| Mar 31, 2025 | 12.61 Mn |
| Sep 30, 2024 | 11.52 Mn |
| Jun 30, 2024 | 11.92 Mn |
| Mar 31, 2024 | 13.90 Mn |
| Sep 30, 2023 | 13.94 Mn |
| Jun 30, 2023 | 15.59 Mn |
| Mar 31, 2023 | 15.94 Mn |
| Sep 30, 2022 | 18.14 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 18.90 Mn |
| Sep 30, 2021 | 17.55 Mn |
| Jun 30, 2021 | 15.34 Mn |
| Mar 31, 2021 | 13.91 Mn |
| Sep 30, 2020 | 6.12 Mn |
| Jun 30, 2020 | 4.00 Mn |
| Mar 31, 2020 | 2.63 Mn |